Codi QR

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

Abstract Background Data on the prevalence of perennial versus seasonal allergic asthma in Italy are lacking; moreover, there is limited evidence on the effect of omalizumab on patient-reported outcomes in Italian patients with severe allergic asthma. PROXIMA, an observational, multicenter study, wa...

Descripció completa

Guardat en:
Autors principals: Giorgio Walter Canonica, Paola Rottoli, Caterina Bucca, Maria Cristina Zappa, Giovanni Michetti, Bruno Macciocchi, Cristiano Caruso, Pierachille Santus, Marta Bartezaghi, Laura Rigoni, on behalf of PROXIMA study centers
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018-11-01
Col·lecció:World Allergy Organization Journal
Matèries:
Omalizumab
Severe allergic asthma
Asthma control
Exacerbations
Quality of life
Perennial allergens
Accés en línia:http://link.springer.com/article/10.1186/s40413-018-0214-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars